A Dutch validation study of the Multiple Sclerosis Work Difficulties Questionnaire in relapsing remitting multiple sclerosis.


Journal

Disability and rehabilitation
ISSN: 1464-5165
Titre abrégé: Disabil Rehabil
Pays: England
ID NLM: 9207179

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 9 11 2019
medline: 13 7 2021
entrez: 9 11 2019
Statut: ppublish

Résumé

The current study aimed to evaluate the psychometric properties of the Dutch version of the Multiple Sclerosis Work Difficulties Questionnaire-23 (MSWDQ-23). Two hundred and thirty-nine employed persons with multiple sclerosis (MS) and 59 healthy controls completed the MSWDQ-23. To verify the factor structure, a confirmatory factor analysis was conducted. To assess construct validity, the MSWDQ-23 scores were correlated to measures of physical disability, fatigue, cognitive and neuropsychiatric problems, depression, health-related quality of life, and work-related variables. MSWDQ-23 scores were compared within different age groups, gender, education levels, and job types. Predictive validity was assessed using a logistic regression analysis to predict a deterioration in employment status after one year based on MSWDQ-23 scores. The internal consistency of the MSWDQ-23 was acceptable ( The Dutch version of the MSWDQ-23 is a valid and internally consistent instrument to measure self-reported work difficulties in persons with MS.Implications for rehabilitationThe Dutch version of the 23-item Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23) is a reliable and valid tool to measure self-reported work difficulties in people with multiple sclerosis (MS).More psychological and cognitive work difficulties are predictive of a deteriorated employment status after one year.The MSWDQ-23 is a helpful tool for researchers and (occupational) health professionals to identify current work difficulties in persons with MS and identify persons at risk for a deterioration in employment one year later.

Identifiants

pubmed: 31702954
doi: 10.1080/09638288.2019.1686072
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1924-1933

Auteurs

Elianne van Egmond (E)

National Multiple Sclerosis Foundation, Rotterdam, The Netherlands.
Department of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, The Netherlands.
Department of Neurology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.

Dennis van Gorp (D)

National Multiple Sclerosis Foundation, Rotterdam, The Netherlands.
Department of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, The Netherlands.
Department of Neurology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
Department of Care Ethics, University of Humanistic Studies, Utrecht, The Netherlands.

Cynthia Honan (C)

Discipline of Psychology, School of Medicine, University of Tasmania, Tasmania, Australia.

Marco Heerings (M)

National Multiple Sclerosis Foundation, Rotterdam, The Netherlands.

Peter Jongen (P)

MS4 Research Institute, Nijmegen, The Netherlands.
Department of Community and Occupational Medicine, University Medical Centre Groningen, Groningen, The Netherlands.

Jac van der Klink (J)

Department of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands.

Michiel Reneman (M)

Department of Rehabilitation, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.

Ernesto Beenakker (E)

Department of Neurology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.

Stephan Frequin (S)

Department of Neurology, St. Antonius Hospital, Nieuwegein, The Netherlands.

Koen de Gans (K)

Department of Neurology, Groene Hart Hospital, Gouda, The Netherlands.

Gerald Hengstman (G)

Department of Neurology, Catharina Hospital, Eindhoven, The Netherlands.

Elske Hoitsma (E)

Department of Neurology, Alrijne Hospital Leiden, Leiden, The Netherlands.

Jop Mostert (J)

Department of Neurology, Rijnstate Hospital, Arnhem, The Netherlands.

Wim Verhagen (W)

Department of Neurology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.

Désirée Zemel (D)

Department of Neurology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

Huub Middelkoop (H)

Department of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, The Netherlands.
Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.

Leo Visser (L)

Department of Neurology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
Department of Care Ethics, University of Humanistic Studies, Utrecht, The Netherlands.

Karin van der Hiele (K)

National Multiple Sclerosis Foundation, Rotterdam, The Netherlands.
Department of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, The Netherlands.
Department of Neurology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH